Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 CNS 1

Conditions

Interventions

Magnetic Resonance Spectroscopy 77 Temozolomide 73 Specimen Handling 49 Radiotherapy 46 Radiosurgery 34 Cyclophosphamide 28 Bevacizumab 26 Radiation 25 pembrolizumab 24 Biopsy 23 Nivolumab 21 Carboplatin 16 fludarabine 14 X-Rays 14 Lomustine 13 Ipilimumab 13 Surgical Procedures, Operative 12 Irinotecan 12 Vincristine 11 Topotecan 11 Cisplatin 11 Blood Specimen Collection 11 dinutuximab 10 trametinib 9 abemaciclib 9 AZD 6244 9 lutetium Lu 177 dotatate 8 Immunoglobulin G 8 Etoposide 8 Doxorubicin 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

varlilumab × CNS × 90 days × Clear all

NCT03688178 2026-05-22

DERIVe

Duke University

Phase 2 Active not recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡